Mail

By The Scientist staff | April 1, 2011


Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Re: Bob Grant’s article about worm therapy for autoimmune disease:[1. Bob Grant, “Opening a Can of Worms,” The Scientist, 25:42-47, February 2011.] A minireview by Hanada et al., (Biol Chem, 391:1365-70, 2010) of the RANKL/RANK system involving T-cell membrane protein ligands and ligand targets in various tissues, including specific neural and astroglial terrains in the brain, may provide additional support to the findings that inflammatory responses could play a role in autism.

Mel Winestock
ABD Laboratories
Oceanside, CA
melthemalicious@yahoo.com

Re: Your article about sustainable farming:[2. Vanessa Schipani, “Alternative Agriculture,” The Scientist, 25:60-62, February 2011.] In South Africa, where the free market adoption of genetically modified (GM) maize has risen to about 80 percent of the total hectarage grown, and even more for cotton, the crops ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development